PRRUF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Immutep (PRRUF) Ownership - Who owns Immutep?

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

264 George Street

Phone

+61 283157003

Employees

Web

https://www.immutep.com

Details

Group

Domestic Stock Funds

Fundamentals

PRRUF

Capitalization

232M

P/E Ratio

N/A

Risk (Beta)

0.97

Dividend Yield

N/A

Total Cash

159M

Total Cash/Share

0.11

Total Debt

1.69M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

172M

P/B Ratio

2.69

Cash Flow

N/A

Earnings

-0.03

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

543M

Current Ratio

18.86

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-43.83M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-28.66

Shares Held By Institutions

72M

Shares Outstanding - Current

1.46B

Total Liabilities

9.86M

Total Volume MTD

N/A

Value

-1

Gain YTD

-1.937

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology